Ancef and Cardiac tamponade - a phase IV clinical study of FDA data
Summary:
Cardiac tamponade is reported as a side effect among people who take Ancef (cefazolin sodium), especially for people who are male, 60+ old, also take Toprol-Xl, and have Bleeding disorders.
The phase IV clinical study analyzes which people have Cardiac tamponade when taking Ancef. It is created by eHealthMe based on reports of 3,257 people who have side effects when taking Ancef from the FDA, and is updated regularly.
What is Ancef?
Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,292 Ancef users. Check the latest studies of Ancef.
What is Cardiac tamponade?
Cardiac tamponade (fluid accumulates in heart covering) is found to be associated with 527 drugs and 774 conditions by eHealthMe. Check the latest studies of Cardiac tamponade.
3,257 people reported to have side effects when taking Ancef.
Among them, 12 people (0.37%) have Cardiac tamponade.

Among these 12 people:
What is the gender of people who have Cardiac tamponade when taking Ancef? *
- female: 41.67 %
- male: 58.33 %
What is the age of people who have Cardiac tamponade when taking Ancef? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 9.09 %
- 50-59: 9.09 %
- 60+: 81.82 %
What are other drugs people take besides Ancef? *
- Colace: 5 people, 41.67%
- Toprol-Xl: 5 people, 41.67%
- Lipitor: 4 people, 33.33%
- Lopressor: 4 people, 33.33%
- Ondansetron: 4 people, 33.33%
- Morphine: 4 people, 33.33%
- Klor-Con: 4 people, 33.33%
- Bisacodyl: 4 people, 33.33%
- Pantoprazole: 4 people, 33.33%
- Albuterol: 4 people, 33.33%
What are other side effects people have besides Cardiac tamponade? *
- Hypotension (abnormally low blood pressure): 6 people, 50.00%
- Cardiac Failure Congestive: 5 people, 41.67%
- Pericardial Haemorrhage (bleeding into the heart): 5 people, 41.67%
- Pain: 4 people, 33.33%
- Post Procedural Haemorrhage (post procedural bleeding): 4 people, 33.33%
- Thrombocytopenia (decrease of platelets in blood): 3 people, 25.00%
- Acute Kidney Failure: 3 people, 25.00%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 25.00%
- Weakness: 3 people, 25.00%
- Injury: 2 people, 16.67%
What are the existing conditions these people have? *
- Type 1 Diabetes: 1 person, 8.33%
- High Blood Pressure: 1 person, 8.33%
- Bleeding Disorders: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Ancef and have Cardiac tamponade?
- Check whether Cardiac tamponade is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ancef:
- Ancef (3,292 reports)
Cardiac tamponade treatments and more:
- Cardiac tamponade (6,153 reports)
How severe was Cardiac tamponade and when was it recovered:
Expand to all the drugs that have ingredients of cefazolin sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ancef:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cardiac tamponade:
- Cardiac tamponade (527 drugs)
Browse all the conditions that are associated with Cardiac tamponade:
- Cardiac tamponade (774 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Ancef) and Ancef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sulfadiazine cause Eosinophilia? - now
- Pulmicort and Stress And Anxiety for Women aged 30-39 - a second ago
- Pulmicort and Anxiolytic Therapy for Women aged 30-39 - 2 seconds ago
- Pulmicort and Tension for Women aged 30-39 - 2 seconds ago
- Pulmicort and Stress for Women aged 30-39 - 2 seconds ago
- Pulmicort and Anxiety, Apprehension, Feeling Uptight, Jitters, Stress, Stress And Anxiety, Tension for Women aged 30-39 - 2 seconds ago
- Pulmicort and Jitters for Women aged 30-39 - 3 seconds ago
- Pulmicort and Feeling Uptight for Women aged 30-39 - 3 seconds ago
- Pulmicort and Apprehension for Women aged 30-39 - 3 seconds ago
- Pulmicort and Anxiety for Women aged 30-39 - 4 seconds ago